Bodybuilders and others who want to build muscle utilize Dindolyl Methane (or DIM). Recent studies have revealed that DIM could pose health hazards. For instance, DIM can cause serious liver damage when consumed in excess. Kidney damage can also be a risk, and could result in kidney failure. The potential long-term health risks of DIM have many athletes and bodybuilders ask the question: should I use an supplement with DIM?
To increase testosterone production it is common to take diindolylmethane supplemental. Testosterone is known to act as an anandrogen, meaning that it can cause hormonal changes in tissues. Studies have shown DIM to mimic the effects both of testosterone and other hormones. Because men produce much more testosterone than women do, some manufacturers have added diindolylmethane into their products in order to make them more competitive in male circles. Men will respond to products that are similar to testosterone that is naturally produced.
This is why numerous companies promote DIM as a cancer-fighter. While diindolylmethane has been proven effective in reducing the growth of tumors in laboratory animals it was given orally to the animals. To achieve the same result in humans, diindolylmethane has to be consumed in high doses over a prolonged period of time. In addition, while the animals tested were cancer-free for a number of years, they all had liver problems at some point, likely due to the excessive diindolylmethane circulating in their system. A doctor can provide you more information about how DIM is absorbed by the body.
According to the US National Institute of Environmental Health Safety and Security, the only way to demonstrate that DIM is effective in treating breast cancer is to perform an experiment wherein cells from healthy breast cancer cells are exposed to high doses of diindolylmethane for a long period of time. There are pros and negatives to using DIM just like any chemical. The ability to mimic hormones is one of the advantages. This means that you could make insulin, which could inhibit cancer cell proliferation. The disadvantages are that diindolylmethane also produces potentially damaging chemicals known as DMSO. Read more about where to buy diindolylmethane here.
One of the most commonly used claims about diindolylmethane’s usage as an treatment for various ailments is that it functions as an natural, antibacterial, anticancer and anti-fungal agent. The National Institute of Health, through an exhaustive review of the supporting evidence, concluded that there was no basis for these claims. According to the Institute of Chemical Technology there were no studies that support this claim. In a thorough examination of the safety profile of the firestone, the Institute of Chemical Safety concluded that the evidence of pharmaceutical companies about the human benefits of diindolylmethane were not reliable.
In the May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and colleagues. Van der Goes, and. have highlighted the potential dangers of diindolylmethane, which includes skin rash and allergic reactions asthma attacks as well as dizziness, headaches and respiratory problems. They also said that the recommended daily dose for this chemical is 0.2 milligrams, or about one 10th of a teaspoon. It is not known what the concentration will be when this chemical is mixed with other substances. This substance is not safe since it hasn’t been thoroughly examined.
The abstract of the view suggests that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the concept of inhibiting the intracellular inhibition of pyruvate’s pyruvate metabolite via flavenoids, and thus preventing accumulation of oxalates in renal tubule cells and Adenine granulocytes. The toxicology studies of the drug metabiplicate have not proven that this chemical can cause overdose. In June 1996, the Food and Drug Administration approved the drug as a prescription drug. According to the FDA the company that manufactures firestone Tincture is in the process of completing two major trials in Europe and the United States.
The view abstract also indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principal of inhibiting the intracellular inhibition of pyruvate metabolite by flavenoids, thereby blocking the accumulation of oxalates in renal tubule cells as well as Adenine granulocytes. However, the drug metabiplicate studies failed to provide convincing evidence that the consumption of this chemical triggers an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the manufacturer of firestone tincture is in process of completing two major trials – one in Europe and another in the United States. According to FDA, the FDA states that the manufacturer of firestone Tincture is currently conducting two major trials in Europe and one in the United States.